Strategies utilized in a search for new drugs active against blood neoplasia von Wieslaw Wiktor Jedrzejczak

Volltext

Computer-assisted frameworks for classification of liver, breast and blood neoplasias via neural networks: A survey based on medical images von Brunetti, Antonio, Carnimeo, Leonarda, Trotta, Gianpaolo Francesco, Bevilacqua, Vitoantonio

Volltext

CDK6 Is a Therapeutic Target in Myelofibrosis von Dutta, Avik, Nath, Dipmoy, Yang, Yue, Le, Bao T, Mohi, Golam

Volltext

Association between Toxoplasma gondii exposure and paediatrics haematological malignancies: a case–control study von Kalantari, Narges, Rezanejad, Javad, Tamadoni, Ahmad, Ghaffari, Salman, Alipour, Jaber, Bayani, Masomeh

Volltext

Theranostic Potentials of Gold Nanomaterials in Hematological Malignancies von Shakil, Md Salman, Niloy, Mahruba Sultana, Mahmud, Kazi Mustafa, Kamal, Mohammad Amjad, Islam, Md Asiful

Volltext

Consequences of combining siRNA-mediated DNA methyltransferase 1 depletion with 5-aza-2'-deoxycytidine in human leukemic KG1 cells von Vispé, Stéphane, Deroide, Arthur, Davoine, Emeline, Desjobert, Cécile, Lestienne, Fabrice, Fournier, Lucie, Novosad, Natacha, Bréand, Sophie, Besse, Jérôme, Busato, Florence, Tost, Jörg, De Vries, Luc, Cussac, Didier, Riond, Joëlle, Arimondo, Paola B

Volltext

Augmented use of L-asparaginase markedly improves AYA ALL outcomes: FBMTG prospective MRD2014 study von Nagafuji, Koji, Miyamoto, Toshihiro, Eto, Tetsuya, Kamimura, Tomohiko, Kato, Koji, Miyazaki, Yasuhiko, Wake, Atsushi, Kohno, Kentaro, Takase, Ken, Imamura, Yutaka, Uchida, Naoyuki, Tanimoto, Kazuki, Kawano, Noriaki, Kurokawa, Toshiro, Kondo, Yukio, Ito, Yoshikiyo, Fujisaki, Tomoaki, Tsukada, Junichi, Yonemoto, Koji, Hori, Toshinori, Akashi, Koichi

Volltext

Real-world characteristics, treatment patterns, and outcomes of patients with 2 or more LOTs for CLL/SLL in the United States von Davids, Matthew S., Ambrose, Jacob, de Nigris, Enrico, Prescott, Jennifer, Leng, Siyang, Farooqui, Mohammed Z. H., Gandra, Shravanthi R., Zettler, Christina M., Fernandes, Laura L., Wang, Ching Kun, Shadman, Mazyar

Volltext

JAK1/2 inhibitor ruxolitinib for the treatment of systemic chronic active Epstein-Barr virus disease: a phase 2 study von Uemura, Yu, Yamamoto, Masahide, Ishimura, Masataka, Kanegane, Hirokazu, Sawada, Akihisa, Hirakawa, Akihiro, Imadome, Ken-Ichi, Yoshimori, Mayumi, Nagata, Masashi, Yamamoto, Kouhei, Shimizu, Norio, Koike, Ryuji, Arai, Ayako

Volltext

Phase 1b study of the anti-CD38 antibody mezagitamab in patients with relapsed/refractory multiple myeloma von Krishnan, Amrita Y., Patel, Krina K., Mohan, Meera, Jagannath, Sundar, Niesvizky, Ruben, Silbermann, Rebecca W., Yu, Ziji, Long, Tao, McDonnell, Scott R. P., Berg, Deborah, Stockerl-Goldstein, Keith E.

Volltext

COVID-19 vaccination in patients with classic and variant hairy cell leukemia von Kreitman, Robert J., James, Lacey, Feurtado, Julie, Eager, Holly, Sierra Ortiz, Olena, Gould, Mory, Shpilman, Isaac, Zhou, Hong, Burbelo, Peter D., Cohen, Jeffrey I., Wang, Hao-Wei, Yuan, Constance M., Arons, Evgeny

Volltext

Development and characterization of a low-affinity humanized CD19 chimeric antigen receptor for B-cell malignancies von Stern, Lawrence A., Vyas, Vibhuti, Lim, Laura, Huynh, Christian, Urak, Ryan, Espinosa, Ruby, Wang, Zhiqiang, Silva Thiel, Michalina, Williams, John C., Forman, Stephen J., Brown, Christine E., Wang, Xiuli

Volltext

A phase 1 study adding pitavastatin to venetoclax therapy in AML and CLL/SLL: a mechanism-based drug repurposing strategy von Brem, Elizabeth A., Shieh, Kevin, Juarez, Dennis, Buono, Roberta, Jeyakumar, Deepa, O’Brien, Susan, Taylor, Thomas H., Fruman, David A.

Volltext

Clinical and pathological features of pediatric peripheral T-cell lymphoma after solid organ transplantation von Cheng, Jinjun, Mariani, Rachel, Punia, Jyotinder Nain, de la Cruz Bonilla, Marimar, Nithagon, Pichayut, Ozdemirli, Metin, Shuai, Wen, Wang, Larry, Abla, Oussama, Gong, Shunyou

Volltext

Intensive chemotherapy after hypomethylating agent and venetoclax in adult acute myeloid leukemia von Chin, Kuo-Kai, Valtis, Yannis, Derkach, Andriy, Yisraeli Salman, Meira, Boussi, Leora, Ciervo, Jenna, Geyer, Mark B., Park, Jae H., Tallman, Martin S., Glass, Jacob L., Goldberg, Aaron D., Stein, Eytan M.

Volltext

CD38-CAR human NK cells in combination with ATRA enhance cytotoxicity against CD38-expressing hematologic malignancies von Troy, Ella, Caporale, Joseph, Sezgin, Yasemin, Pereira, Marcelo S. F., Behbehani, Gregory, Lyberger, Justin, Lee, Dean A., Naeimi Kararoudi, Meisam

Volltext

Lenalidomide, ixazomib, or daratumumab maintenance therapy in multiple myeloma von Lai, Eunice, Soon, Yu Yang, Lee, Ainsley Ryan Yan Bin, Wong, Shi Yin, Soekojo, Cinnie Yentia, Ooi, Melissa, Chng, Wee Joo, de Mel, Sanjay

Volltext

Single-cell and spatial characterization of plasmablast-like lymphoma cells in primary central nervous system lymphoma von Kobayashi, Hiroki, Chijimatsu, Ryota, Naoi, Yusuke, Otani, Yoshihiro, Mizuta, Ryo, Fujii, Kentaro, Ishida, Joji, Murakami, Hiroyuki, Ujiie, Hideki, Ikeuchi, Kazuhiro, Urata, Tomohiro, Seike, Keisuke, Fujiwara, Hideaki, Asada, Noboru, Fujii, Nobuharu, Matsuoka, Ken-ichi, Sato, Yasuharu, Yoshinobu, Maeda, Ennishi, Daisuke

Volltext

Ibrutinib and venetoclax in combination for chronic lymphocytic leukemia: synergy in practice von Timofeeva, Natalia, Jain, Nitin, Gandhi, Varsha

Volltext

Addition of navitoclax to ruxolitinib for patients with myelofibrosis with progression or suboptimal response von Pemmaraju, Naveen, Somervaille, Tim C.P., Palandri, Francesca, Harrison, Claire, Komrokji, Rami S., Perkins, Andrew, Ayala Diaz, Rosa M., Lavie, David, Tomita, Akihiro, Feng, Yang, Qin, Qin, Harb, Jason, Polepally, Akshanth R., Potluri, Jalaja, Garcia, Jacqueline S.

Volltext